243 related articles for article (PubMed ID: 33882314)
1. High-content, targeted RNA-seq screening in organoids for drug discovery in colorectal cancer.
Norkin M; Ordóñez-Morán P; Huelsken J
Cell Rep; 2021 Apr; 35(3):109026. PubMed ID: 33882314
[TBL] [Abstract][Full Text] [Related]
2. TORNADO-seq: A Protocol for High-Throughput Targeted RNA-seq-Based Drug Screening in Organoids.
Norkin M; Huelsken J
Methods Mol Biol; 2023; 2650():65-75. PubMed ID: 37310624
[TBL] [Abstract][Full Text] [Related]
3. First-in-Class Inhibitors of Oncogenic CHD1L with Preclinical Activity against Colorectal Cancer.
Abbott JM; Zhou Q; Esquer H; Pike L; Broneske TP; Rinaldetti S; Abraham AD; Ramirez DA; Lunghofer PJ; Pitts TM; Regan DP; Tan AC; Gustafson DL; Messersmith WA; LaBarbera DV
Mol Cancer Ther; 2020 Aug; 19(8):1598-1612. PubMed ID: 32499299
[TBL] [Abstract][Full Text] [Related]
4. Organoid modelling identifies that DACH1 functions as a tumour promoter in colorectal cancer by modulating BMP signalling.
Hu X; Zhang L; Li Y; Ma X; Dai W; Gao X; Rao X; Fu G; Wang R; Pan M; Guo Q; Xu X; Zhou Y; Gao J; Zhang Z; Cai S; Peng J; Hua G
EBioMedicine; 2020 Jun; 56():102800. PubMed ID: 32512510
[TBL] [Abstract][Full Text] [Related]
5. Drug repurposing screening and mechanism analysis based on human colorectal cancer organoids.
Mao Y; Wang W; Yang J; Zhou X; Lu Y; Gao J; Wang X; Wen L; Fu W; Tang F
Protein Cell; 2024 Apr; 15(4):285-304. PubMed ID: 37345888
[TBL] [Abstract][Full Text] [Related]
6. Sphere‑forming assay vs. organoid culture: Determining long‑term stemness and the chemoresistant capacity of primary colorectal cancer cells.
Zhao H; Yan C; Hu Y; Mu L; Huang K; Li Q; Li X; Tao D; Qin J
Int J Oncol; 2019 Mar; 54(3):893-904. PubMed ID: 30664193
[TBL] [Abstract][Full Text] [Related]
7. Grouped-seq for integrated phenotypic and transcriptomic screening of patient-derived tumor organoids.
Wu Y; Li K; Li Y; Sun T; Liu C; Dong C; Zhao T; Tang D; Chen X; Chen X; Liu P
Nucleic Acids Res; 2022 Mar; 50(5):e28. PubMed ID: 34893868
[TBL] [Abstract][Full Text] [Related]
8. Regulatory network analysis of Paneth cell and goblet cell enriched gut organoids using transcriptomics approaches.
Treveil A; Sudhakar P; Matthews ZJ; Wrzesiński T; Jones EJ; Brooks J; Ölbei M; Hautefort I; Hall LJ; Carding SR; Mayer U; Powell PP; Wileman T; Di Palma F; Haerty W; Korcsmáros T
Mol Omics; 2020 Feb; 16(1):39-58. PubMed ID: 31819932
[TBL] [Abstract][Full Text] [Related]
9. Nutrient sensing by absorptive and secretory progenies of small intestinal stem cells.
Kishida K; Pearce SC; Yu S; Gao N; Ferraris RP
Am J Physiol Gastrointest Liver Physiol; 2017 Jun; 312(6):G592-G605. PubMed ID: 28336548
[TBL] [Abstract][Full Text] [Related]
10. Advancing Drug Discovery for Neurological Disorders Using iPSC-Derived Neural Organoids.
Costamagna G; Comi GP; Corti S
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800815
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic heterogeneity of 2D organoid reflects clinical tumor characteristics.
Fujino S; Ito A; Ohue M; Yasui M; Mizushima T; Doki Y; Mori M; Miyoshi N
Biochem Biophys Res Commun; 2019 May; 513(2):332-339. PubMed ID: 30955861
[TBL] [Abstract][Full Text] [Related]
12. Characterization of normal and cancer stem-like cell populations in murine lingual epithelial organoids using single-cell RNA sequencing.
Johansson E; Ueno H
Sci Rep; 2021 Nov; 11(1):22329. PubMed ID: 34785704
[TBL] [Abstract][Full Text] [Related]
13. Cell-type-specific signaling networks in heterocellular organoids.
Qin X; Sufi J; Vlckova P; Kyriakidou P; Acton SE; Li VSW; Nitz M; Tape CJ
Nat Methods; 2020 Mar; 17(3):335-342. PubMed ID: 32066960
[TBL] [Abstract][Full Text] [Related]
14. Wnt-driven LARGE2 mediates laminin-adhesive O-glycosylation in human colonic epithelial cells and colorectal cancer.
Dietinger V; García de Durango CR; Wiechmann S; Boos SL; Michl M; Neumann J; Hermeking H; Kuster B; Jung P
Cell Commun Signal; 2020 Jun; 18(1):102. PubMed ID: 32586342
[TBL] [Abstract][Full Text] [Related]
15. Multidimensional Screening Platform for Simultaneously Targeting Oncogenic KRAS and Hypoxia-Inducible Factors Pathways in Colorectal Cancer.
Bousquet MS; Ma JJ; Ratnayake R; Havre PA; Yao J; Dang NH; Paul VJ; Carney TJ; Dang LH; Luesch H
ACS Chem Biol; 2016 May; 11(5):1322-31. PubMed ID: 26938486
[TBL] [Abstract][Full Text] [Related]
16. Proteomic Profiling of Enteroid Cultures Skewed toward Development of Specific Epithelial Lineages.
Luu L; Matthews ZJ; Armstrong SD; Powell PP; Wileman T; Wastling JM; Coombes JL
Proteomics; 2018 Aug; 18(16):e1800132. PubMed ID: 29952134
[TBL] [Abstract][Full Text] [Related]
17. The future of cerebral organoids in drug discovery.
Salick MR; Lubeck E; Riesselman A; Kaykas A
Semin Cell Dev Biol; 2021 Mar; 111():67-73. PubMed ID: 32654970
[TBL] [Abstract][Full Text] [Related]
18. Oligomeric proanthocyanidins (OPCs) target cancer stem-like cells and suppress tumor organoid formation in colorectal cancer.
Toden S; Ravindranathan P; Gu J; Cardenas J; Yuchang M; Goel A
Sci Rep; 2018 Feb; 8(1):3335. PubMed ID: 29463813
[TBL] [Abstract][Full Text] [Related]
19. 3D imaging of colorectal cancer organoids identifies responses to Tankyrase inhibitors.
Badder LM; Hollins AJ; Herpers B; Yan K; Ewan KB; Thomas M; Shone JR; Badder DA; Naven M; Ashelford KE; Hargest R; Clarke AR; Esdar C; Buchstaller HP; Treherne JM; Boj S; Ramezanpour B; Wienke D; Price LS; Shaw PH; Dale TC
PLoS One; 2020; 15(8):e0235319. PubMed ID: 32810173
[TBL] [Abstract][Full Text] [Related]
20. FGF Signalling in the Self-Renewal of Colon Cancer Organoids.
Otte J; Dizdar L; Behrens B; Goering W; Knoefel WT; Wruck W; Stoecklein NH; Adjaye J
Sci Rep; 2019 Nov; 9(1):17365. PubMed ID: 31758153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
